Organization
General Hospital of Shenyang Military Region
17 clinical trials
Clinical trial
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis: A Prospective Non-randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2): a Prospective, Randomized, Open Label, Blinded Endpoint, and Multi-center StudyStatus: Recruiting, Estimated PCD: 2025-03-15
Clinical trial
The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques: a Prospective, Random, Single-center Study Based on High Resolution Magnetic Resonance ImagingStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
Efficacy and Safety of Local Glucocorticoids for the Treatment of Radiation-Induced Intestinal Injury: A Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2026-12-31
Clinical trial
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation: a Prospective, Multicenter, Cohort StudyStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Efficacy and Safety of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With End-stage Liver DiseasesStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Efficacy and Safety of Different Frequencies of Human Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With End-stage Liver DiseaseStatus: Not yet recruiting, Estimated PCD: 2025-01-01
Clinical trial
Fingolimod for Type 2 Diabetes Mellitus: a Pilot, Prospective, Randomized, and Open Label Single-center StudyStatus: Recruiting, Estimated PCD: 2024-03-15
Clinical trial
Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke (UMSIS): a Prospective, Double-blinded, Randomized Controlled, Pilot StudyStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Intra-arterial Tenecteplase During First Thrombectomy Attempt for Acute Stroke (BRETIS-TNK II): a Prospective, Randomized, Adaptive Enrichment, Open-label, Blinded End Point, Multi-center StudyStatus: Recruiting, Estimated PCD: 2025-03-15
Clinical trial
Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST): a Prospective, Random, Double Blinded and Multi-center StudyStatus: Recruiting, Estimated PCD: 2024-07-28
Clinical trial
Improving Neurological Outcome for Acute Basilar Artery Occlusion With Sufficient Recanalization After Thrombectomy by Intraarterial Tenecteplase (INSIST-IT): a Prospective, Randomized, Open-label, Blinded-end Point, Multicenter TrialStatus: Recruiting, Estimated PCD: 2025-03-15
Clinical trial
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis: A Single-center, Prospective, Cohort StudyStatus: Completed, Estimated PCD: 2022-12-01
Clinical trial
Rescue Thrombolysis for Medium Vessel Occlusion (RESCUE-TNK): a Prospective, Randomized, Open-label, Blinded End Point, and Multicenter TrialStatus: Recruiting, Estimated PCD: 2025-03-15
Clinical trial
INtravenous TNK for Acute isChemicsTroke in China (INTACT-China): a Prospective, Multi-center, Registry StudyStatus: Completed, Estimated PCD: 2024-04-09
Clinical trial
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE): A Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2027-06-30
Clinical trial
Improving Neurological Outcome for Acute Basilar Artery Occlusion With Sufficient Recanalization After Thrombectomy by Intraarterial Tenecteplase (INSIST-IT): a Prospective, Randomized, Open-label, Blinded-end Point, Multicenter TrialStatus: Recruiting, Estimated PCD: 2025-03-15